Kras inhibitors

TW202633890APending Publication Date: 2026-08-16ELI LILLY & CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114137495
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-08-28
Filing Date
2025-09-30
Publication Date
2026-08-16
Patent Text Reader

Abstract

Provided herein are compounds of the formula: wherein A, B, R1, R2, R3a, R3b, Z1, Z2, and Z3 are as described herein, pharmaceutically acceptable salts thereof, and methods of using these compounds and pharmaceutically acceptable salts thereof for treating patients with cancer.
Need to check novelty before this filing date? Find Prior Art